Pneumocystis carinii Pneumonia Global Clinical Trials Review, H1, 2018
May 2018
50
About the Report
About the Report
Pneumocystis carinii Pneumonia Global Clinical Trials Review, H1, 2018
Summary
GlobalData's clinical trial report, Pneumocystis carinii Pneumonia Global Clinical Trials Review, H1, 2018 provides an overview of Pneumocystis carinii Pneumonia clinical trials scenario. This report provides top line data relating to the clinical trials on Pneumocystis carinii Pneumonia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Products
Products
Pneumocystis carinii Pneumonia Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CROs, Terminated, Suspended and Withdrawn trials of Pneumocystis carinii Pneumonia, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania
Companies
GlaxoSmithKline Plc Jacobus Pharmaceutical Company U S Bioscience Inc Sanofi Immtech Pharmaceuticals Inc Holley Group Co Ltd Cipla Ltd AstraZeneca Plc Astellas Pharma Inc Allergan Plc
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Pneumocystis carinii Pneumonia to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Pneumocystis carinii Pneumonia to Infectious Disease Clinical Trials 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Pneumocystis carinii Pneumonia Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 48
Abbreviations 48
Definitions 48
Research Methodology 49
Secondary Research 49
About GlobalData 50
Contact Us 50
Source 50
List of Figure
List of Figures
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 9
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Europe, Top Countries (%), 2018* 10
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 12
Proportion of Pneumocystis carinii Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 13
Pneumocystis carinii Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
Pneumocystis carinii Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
Proportion of Pneumocystis carinii Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 16
Pneumocystis carinii Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 17
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2018* 18
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 19
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2018* 20
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2018* 21
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 22
Pneumocystis carinii Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 23
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 24
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 25
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 26
GlobalData Methodology 49
List of Table
List of Tables
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials by Region, 2018* 6
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 9
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Europe, Top Countries, 2018* 10
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 12
Proportion of Pneumocystis carinii Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 13
Pneumocystis carinii Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
Pneumocystis carinii Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
Proportion of Pneumocystis carinii Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 16
Pneumocystis carinii Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 17
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2018* 18
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 19
Pneumocystis carinii Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2018* 20
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2018* 21
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 22
Pneumocystis carinii Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 23
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 24
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 25
Pneumocystis carinii Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 26
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.